39 results on '"Ning Shao"'
Search Results
2. Structural biology of the human papillomavirus
3. Novel intercellular spread mode of respiratory syncytial virus contributes to neutralization escape
4. Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial
5. Major HBV splice variant encoding a novel protein important for infection
6. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
7. Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
8. Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial
9. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
10. Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial
11. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
12. BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma
13. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy
14. Study on the p-type ohmic contact in GaAs-based laser diode
15. The effect of economic policy uncertainty on China’s housing market
16. Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection
17. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients
18. An optimized high-throughput fluorescence plate reader-based RSV neutralization assay
19. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients
20. Dynamic relationship of oil price shocks and country risks
21. Sleeping Beauty transposon-based system for rapid generation of HBV-replicating stable cell lines
22. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection
23. Modeling the long-term antibody response of a hepatitis E vaccine
24. A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box
25. Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial
26. A novel linear neutralizing epitope of hepatitis E virus
27. A highly specific ELISA for diagnosis of 2009 influenza A (H1N1) virus infections
28. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors
29. Hepatitis E
30. Estrogen Receptor α Represses Transcription of HBV Genes via Interaction With Hepatocyte Nuclear Factor 4α
31. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
32. Tetracysteine as a Reporter for Gene Therapy
33. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine
34. Preparation and Identification of a Single-chain Antibody Fragment Against High Pathogenic H5N1 Avian Influenza Virus
35. Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity
36. Mutational Analysis of Essential Interactions Involved in the Assembly of Hepatitis E Virus Capsid
37. Specific interaction between hnRNP H and HPV16 L1 proteins: Implications for late gene auto-regulation enabling rapid viral capsid protein production
38. Evaluation of a new rapid influenza A diagnostic test for detection of pandemic (H1N1) 2009 and seasonal influenza A virus
39. Reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.